First multiplex test for tick-borne diseases

A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tick-borne disease by offering a single test to identify and distinguish between Borrelia burgdorferi, the pathogen responsible for Lyme disease, and seven other tick-borne pathogens. Led by scientists at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health, the research team report details on the new test in the journal Nature:...

What feeling does this article give you?

#hashtags to follow:

Tick [+]    Borne Disease Serochip [+]    TBD Serochip [+]    Borrelia [+]    Lyme [+]    Infection and Immunity [+]    CII [+]    Columbia University [+]   

More #news: